| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,675.00
|
|
Change (%)
|
8.50 (0.51%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
1,655.80
-
1,700.40
|
|
52-Week Range (RS)
|
1,066.00
-
1,739.60
|
|
Beta (1 Year)
|
0.33
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Midcap |
| News |
|
Corporate Details |
| Aurobindo Pharma receives USFDA approval for Beclomethasone Dipropionate HFA Inhalation Aerosol |
| Aurobindo Pharma receives US FDA nod for metered Beclomethasone Dipropionate aerosol |
| Aurobindo Pharma Ltd soars 1.19% |
| Aurobindo Pharma Ltd spurts 3.36%, gains for fifth straight session |
| Aurobindo Pharma's Unit-VI completes USFDA inspection |
| Aurolife Pharma's Raleigh Plant completes USFDA inspection |
| Aurobindo Pharma slides after USFDA issues 11 observations |
| Stock Alert: Aurobindo Pharma, PB Fintech, Biocon, Bikaji Foods Intl, JK Lakshmi Cement |
| Aurobindo Pharma consolidated net profit rises 25.20% in the June 2026 quarter |
| Aurobindo Pharma schedules AGM |
|
|
|
| Incoporation Year : 1986 |
| Chairman : M R Kumar |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Aurobindo Pharma Ltd
Plot No 2 Maitrivihar,
Behind Maithri Vanam Ameerpet,
Hyderabad,
Telangana-500038 |
Phone:91-40-23736370
Fax:91-40-23747340 |
| E-Mail : cs@aurobindo.com; investorgrievances@aurobindo.com |
| URL : http://www.aurobindo.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
24-Sep-2026 |
1720.00 |
-2.62 |
| 1Month |
01-Sep-2026 |
1683.00 |
-0.48 |
| 3Month |
01-Jul-2026 |
1552.80 |
7.87 |
| 6Month |
01-Apr-2026 |
1342.10 |
24.80 |
| 1Year |
01-Oct-2025 |
1087.10 |
54.08 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| HDFC Mid Cap Fund |
2.12 |
2291.29 |
| Quant ELSS Tax Saver Fund |
8.49 |
1142.19 |
| Quant Mid Cap Fund |
10.45 |
841.82 |
| SBI Large & Midcap Fund |
1.91 |
806.99 |
| Quant Multi Cap Fund |
9.46 |
730.98 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,810.00 |
-0.55 |
2,047.55 |
1,583.60 |
434,279.63 |
| Zydus Lifesciences Ltd |
1,145.25 |
-1.56 |
1,232.00 |
835.85 |
114,239.13 |
| Cipla Ltd |
1,346.85 |
-0.23 |
1,672.20 |
1,165.55 |
108,808.05 |
| Laurus Labs Ltd |
1,989.00 |
0.37 |
2,054.55 |
838.40 |
107,468.10 |
| Mankind Pharma Ltd |
2,527.00 |
0.88 |
2,640.30 |
1,909.90 |
104,376.49 |
|
|
|
|